Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paromomycin Access Program for Visceral Leishmaniasis
NCT00604955Phase 4Completed
- Sponsor
- PATH
- Start
- Oct 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paromomycin in visceral leishmaniasis (VL), sponsored by PATH. Started Oct 2007; status: completed.
02
Drugs
paromomycin
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00604955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604955.